1167 — Jacobio Pharmaceuticals Co Balance Sheet
0.000.00%
- HK$2.93bn
- HK$1.84bn
- CNY155.71m
Annual balance sheet for Jacobio Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,627 | 1,538 | 1,284 | 1,143 | 1,175 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 187 | 97.6 | 40.1 | 20.6 | 14.1 |
Total Other Current Assets | |||||
Total Current Assets | 1,815 | 1,640 | 1,339 | 1,168 | 1,189 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 34.1 | 41.8 | 205 | 220 | 151 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,867 | 1,722 | 1,575 | 1,460 | 1,359 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 73.9 | 80.8 | 156 | 205 | 243 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 81.2 | 84.7 | 292 | 387 | 436 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,786 | 1,637 | 1,283 | 1,073 | 923 |
Total Liabilities & Shareholders' Equity | 1,867 | 1,722 | 1,575 | 1,460 | 1,359 |
Total Common Shares Outstanding |